The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma

To determine the frequency and predictive impact of ROS1 rearrangements on treatment outcomes in never-smoking patients with lung adenocarcinoma. We concurrently analyzed ROS1 and ALK rearrangements and mutations in the epidermal growth factor receptor (EGFR), and KRAS in 208 never smokers with lung...

Full description

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 24; no. 9; p. 2364
Main Authors: Kim, H R, Lim, S M, Kim, H J, Hwang, S K, Park, J K, Shin, E, Bae, M K, Ou, S-H I, Wang, J, Jewell, S S, Kang, D R, Soo, R A, Haack, H, Kim, J H, Shim, H S, Cho, B C
Format: Journal Article
Language:English
Published: England 01.09.2013
Subjects:
ISSN:1569-8041, 1569-8041
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first